ADAR1 Capital Management »

Solidion Technology shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Solidion Technology (STI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Solidion Technology

Tip: Access up to 7 years of quarterly data

All positions including Solidion Technology held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Solidion Technology by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $63k 14k 4.64

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Solidion Technology

Hrt Financial
Morgan Stanley
DRW Holdings
Vanguard Group
Geode Capital Management
ADAR1 Capital Management
Russell Investments
FMR
Tower Research Capital
UBS Group
JNBA Financial Advisors
Royal Bank of Canada
NISA Investment Advisors
Bnp Paribas Arbitrage, Snc
Principal Securities

View all funds holding Solidion Technology